Loading financial data...

GSK plc (GLAXF) SEC Filings | Global Financial Data

GSK plc

GLAXFSEC EDGAR

Pharmaceutical Preparations(X0)CIK: 1131399

6-K

US FDA APPROVES AREXVY FOR ADULTS 18-49 AIR

Filed: Mar 13, 2026 | Report: Mar 13, 2026

View on SEC

6-K

TRANSACTION IN OWN SHARES

Filed: Mar 13, 2026 | Report: Mar 13, 2026

View on SEC

6-K

DIRECTOR/PDMR SHAREHOLDING

Filed: Mar 12, 2026 | Report: Mar 12, 2026

View on SEC

6-K

TRANSACTION IN OWN SHARES

Filed: Mar 12, 2026 | Report: Mar 12, 2026

View on SEC

6-K

TRANSACTION IN OWN SHARES

Filed: Mar 11, 2026 | Report: Mar 11, 2026

View on SEC

6-K

TRANSACTION IN OWN SHARES

Filed: Mar 10, 2026 | Report: Mar 10, 2026

View on SEC

6-K

BOARD COMMITTEE CHANGE

Filed: Mar 9, 2026 | Report: Mar 9, 2026

View on SEC

6-K

GSK AND ALFASIGMA AGREE GLOBAL LINERIXIBAT RIGHTS

Filed: Mar 9, 2026 | Report: Mar 9, 2026

View on SEC

6-K

TRANSACTION IN OWN SHARES

Filed: Mar 9, 2026 | Report: Mar 9, 2026

View on SEC

6-K

FILING OF GSK PLC 2025 ANNUAL REPORT ON FORM 20-F

Filed: Mar 6, 2026 | Report: Mar 6, 2026

Filed: Mar 6, 2026 | Report: Dec 31, 2025

View on SEC

6-K

TRANSACTION IN OWN SHARES

Filed: Mar 6, 2026 | Report: Mar 6, 2026

View on SEC

6-K

GSK PUBLISHES ANNUAL REPORT 2025

Filed: Mar 5, 2026 | Report: Mar 5, 2026

View on SEC

6-K

TRANSACTION IN OWN SHARES

Filed: Mar 5, 2026 | Report: Mar 5, 2026

View on SEC

6-K

DIRECTOR/PDMR SHAREHOLDING

Filed: Mar 4, 2026 | Report: Mar 4, 2026

View on SEC

6-K

TRANSACTION IN OWN SHARES

Filed: Mar 4, 2026 | Report: Mar 4, 2026

View on SEC

6-K

GSK COMPLETES ACQUISITION OF RAPT THERAPEUTICS

Filed: Mar 3, 2026 | Report: Mar 3, 2026

View on SEC

6-K

TRANSACTION IN OWN SHARES

Filed: Mar 3, 2026 | Report: Mar 3, 2026

TRANSACTION IN OWN SHARES

Filed: Mar 2, 2026 | Report: Mar 2, 2026

View on SEC

6-K

TOTAL VOTING RIGHTS

Filed: Mar 2, 2026 | Report: Mar 2, 2026

View on SEC

6-K

DIRECTOR/PDMR SHAREHOLDING

Filed: Feb 27, 2026 | Report: Feb 27, 2026

View on SEC

6-K

TRANSACTION IN OWN SHARES

Filed: Feb 27, 2026 | Report: Feb 27, 2026

View on SEC

6-K

LINERIXIBAT ACCEPTED FOR PRIORITY REVIEW IN CHINA

Filed: Feb 26, 2026 | Report: Feb 26, 2026

View on SEC

6-K

BEPIROVIRSEN ACCEPTED FOR JAPAN REGULATORY REVIEW

Filed: Feb 26, 2026 | Report: Feb 26, 2026

View on SEC

6-K

TRANSACTION IN OWN SHARES

Filed: Feb 26, 2026 | Report: Feb 26, 2026

View on SEC

6-K

DIRECTOR/PDMR SHAREHOLDING

Filed: Feb 25, 2026 | Report: Feb 25, 2026

View on SEC

6-K

DIRECTOR/PDMR SHAREHOLDING

Filed: Feb 25, 2026 | Report: Feb 25, 2026

View on SEC

6-K

GSK ENTERS AGREEMENT TO ACQUIRE 35PHARMA

Filed: Feb 25, 2026 | Report: Feb 25, 2026

View on SEC

6-K

TRANSACTION IN OWN SHARES

Filed: Feb 25, 2026 | Report: Feb 25, 2026

View on SEC

6-K

DIRECTOR/PDMR SHAREHOLDING

Filed: Feb 24, 2026 | Report: Feb 24, 2026

View on SEC

6-K

TRANSACTION IN OWN SHARES

Filed: Feb 24, 2026 | Report: Feb 24, 2026

TRANSACTION IN OWN SHARES

Filed: Feb 23, 2026 | Report: Feb 23, 2026

View on SEC

6-K

DIRECTOR/PDMR SHAREHOLDING

Filed: Feb 20, 2026 | Report: Feb 20, 2026

View on SEC

6-K

TRANSACTION IN OWN SHARES

Filed: Feb 20, 2026 | Report: Feb 20, 2026

View on SEC

6-K

DIRECTOR/PDMR SHAREHOLDING

Filed: Feb 19, 2026 | Report: Feb 19, 2026

View on SEC

6-K

TRANSACTION IN OWN SHARES

Filed: Feb 19, 2026 | Report: Feb 19, 2026

View on SEC

6-K

TRANSACTION IN OWN SHARES

Filed: Feb 18, 2026 | Report: Feb 18, 2026

View on SEC

6-K

DIRECTOR/PDMR SHAREHOLDING

Filed: Feb 17, 2026 | Report: Feb 17, 2026

View on SEC

6-K

DIRECTOR/PDMR SHAREHOLDING

Filed: Feb 17, 2026 | Report: Feb 17, 2026

View on SEC

6-K

GSK - FOURTH TRANCHE OF SHARE BUYBACK PROGRAMME

Filed: Feb 17, 2026 | Report: Feb 17, 2026

View on SEC

6-K

EXDENSUR APPROVED BY THE EUROPEAN COMMISSION

Filed: Feb 17, 2026 | Report: Feb 17, 2026

View on SEC

6-K

DIRECTOR/PDMR SHAREHOLDING

Filed: Feb 17, 2026 | Report: Feb 17, 2026

View on SEC

6-K

DIRECTOR/PDMR SHAREHOLDING

Filed: Feb 17, 2026 | Report: Feb 17, 2026

View on SEC

6-K

DIRECTOR/PDMR SHAREHOLDING

Filed: Feb 17, 2026 | Report: Feb 17, 2026

View on SEC

13F-HR

Filed: Feb 12, 2026 | Report: Dec 31, 2025

View on SEC

6-K

DIRECTOR/PDMR SHAREHOLDING

Filed: Feb 11, 2026 | Report: Feb 11, 2026

View on SEC

6-K

DIRECTOR/PDMR SHAREHOLDING

Filed: Feb 11, 2026 | Report: Feb 11, 2026

View on SEC

Build with this data

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)

Get API Key (Free)